439083-91-7 Usage
Molecular structure
2-(3,4-diMethoxybenzyl)-7-((2S,3S)-2-hydroxy-6-phenylhexan-3-yl)-5-MethyliMidazo[1,5-f][1,2,4]triazin-4(3H)-one has a long and complex molecular structure.
Methoxy
-OCH3 groups attached to the benzyl ring.
Hydroxy
-OH group present in the (2S,3S)-2-hydroxy-6-phenylhexan-3-yl moiety.
Phenyl
A benzene ring structure (C6H5) attached to the hexan-3-yl group.
Methyl
-CH3 group present in the 5-methyl part of the molecule.
Ring system
The compound features an imidazo[1,5-f][1,2,4]triazin-4(3H)-one ring system, which contributes to its complex structure and potential biological activity.
Pharmaceutical applications
Due to its complex structure and potential biological activity, the compound is likely to have pharmaceutical applications. However, further research is needed to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 439083-91-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,9,0,8 and 3 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 439083-91:
(8*4)+(7*3)+(6*9)+(5*0)+(4*8)+(3*3)+(2*9)+(1*1)=167
167 % 10 = 7
So 439083-91-7 is a valid CAS Registry Number.
439083-91-7Relevant academic research and scientific papers
Products and pharmaceutical compositions
-
Page/Page column 20; 21, (2018/01/20)
The present invention relates to a product comprising a PDE1 inhibitor and a PDE2 inhibitor, in free or salt form, pharmaceutical compositions comprising them and their use as pharmaceuticals for the treatment of cAMP and/or cGMP related disorders.
PRODUCTS AND PHARMACEUTICAL COMPOSITIONS
-
Paragraph 0087-0089, (2015/07/23)
The present invention relates to a product comprising a PDE1 inhibitor and a PDE2 inhibitor, in free or salt form, pharmaceutical compositions comprising them and their use as pharmaceuticals for the treatment of cAMP and/or cGMP related disorders.
Substituted imidazotriazinones
-
, (2008/06/13)
The present invention relates to new substituted imidazotriazinones, processes for their preparation, and their use for the production of medicaments, in particular for improving perception, concentration power, learning power and/or memory power.
